The ProvinceEdmonton woman becomes first adult cured of sickle cell anemia in Canada thanks to stem cell transplantThe ProvinceAgyepong was born with sickle-cell anemia, a hereditary disease in which blood cells change into a sickle shape and block blo… Continue reading
CBC.ca |
Alberta woman 1st adult in Canada to be ‘cured’ of sickle cell anemia through stem cell transplant
CBC.ca … that will give her sister a new life. (Nelly Alberola/Radio-Canada). Amoah was tested and was found to be a 100 per cent match for her sister. Daly said the odds of siblings being a perfect match is one in four. The transplant, which took place at … |
CBC.ca |
Alberta woman 1st adult in Canada to be ‘cured’ of sickle cell anemia through stem cell transplant
CBC.ca … that will give her sister a new life. (Nelly Alberola/Radio-Canada). Amoah was tested and was found to be a 100 per cent match for her sister. Daly said the odds of siblings being a perfect match is one in four. The transplant, which took place at … |
CTV News |
Adult recipient of stem cell transplant in Calgary cured of sickle-cell disease
CTV News An Edmonton woman who received donor stem cells from her sister during a procedure in Calgary last year has been declared cured of her sickle-cell disease and health officials believe Revée Agyepong is the first adult in Canada to be cured of the … Stem cell transplant cures first adult sickle-cell patient in CanadaCalgary Herald Canadian first: Stem cell transplant cures Alberta woman of sickle cell anemiaMetroNews Canada Alberta woman 1st adult in Canada to be ‘cured’ of sickle cell anemia through stem cell transplantCBC.ca |
New Atlas |
USDA confirms it won’t regulate CRISPR gene-edited plants like it does GMOs
New Atlas A statement issued by the U.S. Secretary of Agriculture Sonny Perdue last week has clarified that the U.S. Department of Agriculture (USDA) currently does not, and has no plans to, regulate gene edited plants or crops. As opposed to genetically … |
BioWorld Online |
Allogene ‘CAR T-wheels’ into cancer immunotherapy on the tail of a Kite
BioWorld Online The formation of Allogene Therapeutics, which took off with a $300 million series A financing and a portfolio of assets from Pfizer Inc. related to allogeneic chimeric antigen receptor T cell (CAR T) therapy, began with a conversation at a dinner on … |